Trademark Search in Canada

KRYSTEXXA

View On IC.GC.CA

REGISTERED

on 16 Aug 2019

Last Applicant/ Owned by

HORIZON THERAPEUTICS USA INC.

1 Horizon WayDeerfield, IL 60015

Serial Number

1780693 filed on 4^th May 2016

Registration Number

TMA1049647 registered on 16^th Aug 2019

Registration expiry Date

16^th Aug 2029

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

KRYSTEXXA

Trademark usage description

pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or body fluids; biological and pharmaceutical preparatio Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or body fluids; biological and pharmaceutical preparations for the treatment of rheumatic arthritis.

Classification kind code

Mark Details

Serial Number

1780693

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 87 on 13^th May 2019	Rep for Service Changed
Submitted for opposition 51 on 28^th Apr 2017	Allowance Notice Sent
Submitted for opposition 50 on 28^th Apr 2017	Allowed
Submitted for opposition 42 on 11^th Jan 2017	Advertised
Submitted for opposition 26 on 22^nd Dec 2016	Approved
Submitted for opposition 22 on 31^st Oct 2016	Search Recorded
Submitted for opposition 27 on 31^st Oct 2016	Approval Notice Sent
Submitted for opposition 31 on 6^th May 2016	Formalized
Submitted for opposition 1 on 5^th May 2016	Created
Submitted for opposition 30 on 4^th May 2016	Filed

KRYSTEXXA

Classification Information

Class [005]Pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or body fluids; biological and pharmaceutical preparations for the treatment of rheumatic arthritis.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or body fluids; biological and pharmaceutical preparations for the treatment of rheumatic arthritis.